Cargando…
Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
Autores principales: | Owusu-Brackett, Nicci, Oppong, Bridget A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333758/ https://www.ncbi.nlm.nih.gov/pubmed/37441015 http://dx.doi.org/10.21037/gs-23-106 |
Ejemplares similares
-
Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017) -
Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023) -
Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022) -
Dissection of Level III Axillary Lymph Nodes in Breast Cancer
por: Hu, Jiejie, et al.
Publicado: (2021) -
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)